The association between variability of risk factors and complications in type 2 diabetes mellitus: a retrospective study
- PMID: 38491155
- PMCID: PMC10943073
- DOI: 10.1038/s41598-024-56777-w
The association between variability of risk factors and complications in type 2 diabetes mellitus: a retrospective study
Abstract
The variability in diabetes risk factors, such as uric acid and lipids, may influence the development of complications. This study aimed to investigate the influence of such variability on the occurrence of diabetic complications. A retrospective analysis of electronic medical records was conducted with type 2 diabetic patients who received treatment at a tertiary care hospital in Chengdu, Sichuan Province, between 2013 and 2022. The risk factor variability is presented as the standard deviation (SD). The associations between the variability and complications were examined using a binary logistic regression model. The study included 369 patients with type 2 diabetes. The findings revealed that outpatient special disease management served as a protective factor against the development of complications [OR = 0.53, 95% confidence interval (CI) (0.29-0.10)], particularly for the prevention of diabetic peripheral neuropathy [OR = 0.51, 95% CI (0.30-0.86)]. Variability in total cholesterol (TC-SD) was found to be a risk factor for the development of complications [OR = 2.42, 95% CI (1.18-4.97)] and acted as a risk factor for diabetic peripheral vasculopathy [OR = 2.50, 95% CI (1.25-5.02)]. TC-SD is a risk factor for the occurrence of diabetic peripheral neuropathy and diabetic peripheral vasculopathy, whereas outpatient special disease management functions as a protective factor against complications and diabetic peripheral neuropathy. Thus, in addition to glycaemic control, the regulation of lipid levels should be emphasized, particularly among patients without outpatient special disease management, to delay the onset of complications.
Keywords: Complications; Outpatient special disease management; Total cholesterol; Type 2 diabetes mellitus; Variability.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.Diab Vasc Dis Res. 2018 Sep;15(5):424-432. doi: 10.1177/1479164118780808. Epub 2018 Jun 18. Diab Vasc Dis Res. 2018. PMID: 29911415
-
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.Cardiovasc Diabetol. 2018 Feb 24;17(1):33. doi: 10.1186/s12933-018-0677-0. Cardiovasc Diabetol. 2018. PMID: 29477146 Free PMC article.
-
Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.Cardiovasc Diabetol. 2020 May 2;19(1):50. doi: 10.1186/s12933-020-01030-7. Cardiovasc Diabetol. 2020. PMID: 32359350 Free PMC article.
-
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.Diabetologia. 2021 Feb;64(2):275-287. doi: 10.1007/s00125-020-05319-w. Epub 2020 Dec 14. Diabetologia. 2021. PMID: 33313987 Free PMC article.
-
Diabetic Peripheral Neuropathy in Ethiopia: A Systematic Review and Meta-Analysis.J Diabetes Res. 2021 Feb 4;2021:5304124. doi: 10.1155/2021/5304124. eCollection 2021. J Diabetes Res. 2021. PMID: 33628833 Free PMC article.
Cited by
-
Neurological Complications of Type 2 Diabetes Mellitus: A Duration-Based Comparative Study at a Secondary Care Hospital in Karachi, Pakistan.Cureus. 2025 Jul 23;17(7):e88562. doi: 10.7759/cureus.88562. eCollection 2025 Jul. Cureus. 2025. PMID: 40861697 Free PMC article.
-
The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.Front Endocrinol (Lausanne). 2025 Jan 13;15:1463027. doi: 10.3389/fendo.2024.1463027. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39872318 Free PMC article.
References
-
- Bo Z, Wenying Y. Outlook for the epidemiology and prevention of diabetes in China. Chin. J. Diab. 2019;11(1):7–10.
-
- Chinese MADB. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part1) Chin. J. Pract. Internal Med. 2021;41(08):668–695.
-
- Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin. Diab. 2011;26(2):77–82.
-
- Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am. J. Prev. Med. 2013;45(3):253–261. - PubMed
-
- Goldhaber-Fiebert JD, et al. Inpatient treatment of diabetic patients in Asia: Evidence from India, China Thailand and Malaysia. Diabet. Med. 2010;27(1):101–108. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical